Compare Mutual Funds
Risk
Very High
-
Rating
1.0
-
Min SIP Amount
₹500
-
Expense Ratio
2.96
-
NAV
₹18.29
-
Fund Started
18 Oct 2021
-
Fund Size
₹237.99 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
-
1 Year
2.38%
-
3 Year
19.69%
-
5 Year
-
-
Equity
98.25%
-
Cash
1.75%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.40% |
Divi's Laboratories Ltd. | 8.83% |
Apollo Hospitals Enterprise Ltd. | 6.25% |
Max Healthcare Institute Ltd. | 5.22% |
Torrent Pharmaceuticals Ltd. | 4.82% |
Lupin Ltd. | 4.44% |
Aurobindo Pharma Ltd. | 4.36% |
Laurus Labs Ltd. | 4.24% |
Fortis Healthcare Ltd. | 3.11% |
Cohance Lifesciences Ltd. | 3.08% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
-
Launch Date
18 Oct 2021
-
